Data as of Oct 23
| +0.14 / +0.64%|
The Medicines Co. is a pharmaceutical company, which focuses on advancing the treatment of critical care patients through the delivery of medicines to the worldwide hospital marketplace. The company has three marketed products, Angiomax, Cleviprex inject able emulsion and its ready-to-use formulation of Argatroban. Its also have a pipeline of acute and intensive care hospital products in development, including four late-stage development product candidates, cangrelor, oritavancin, MDCO-157 and IONSYS and three early stage development product candidates, MDCO-216, ALN-PCS02 and ALN-PCSsc. Medicines was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.
|Clive A. Meanwell||Chairman & Chief Executive Officer|
|Glenn P. Sblendorio||President, CFO, Treasurer & Director|
|Helmut Giersiefen||Chief Information & Knowledge Officer|
|Gregory Fiore||Chief Medical Officer|
|David Kallend||Vice President & Global Medical Director|